Diagnostics Organizations Join to Produce Series of Reports

DxInsights, a nonprofit, independent organization that provides data on the value and power of diagnostics, and AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) representing leading manufacturers of innovative, safe, and effective medical diagnostic tests, are collaborating on a several short reports that will explain the mechanics of diagnostic technologies.

“Diagnostic tests are ‘smart’ tools that allow medical professionals to understand information from a patient’s body, whether it is a blood glucose test or a DNA test that identifies a cancer patient’s unique genetic markers,” said Andrew Fish, executive director of AdvaMedDx and senior executive vice president of AdvaMed. “Our industry is excited to partner with the team at DxInsights on this initiative that will explain more clearly how advances in diagnostic technology are revolutionizing patient care at every juncture—from diagnosis and prognosis to treatment and follow up care.”

The first report, “Essentials of Diagnostics: Molecular Diagnostics,” is the next installment of DxInsight’s inaugural report, “Essentials of Diagnostics,” which was introduced in January. Future reports will cover such topics as next-generation sequencing, anatomical pathology, and other areas of diagnostic technology relevant to multiple industry stakeholders.

“Molecular diagnostics has exploded over the past 20 years and has revolutionized the diagnosis and monitoring of inherited disease, cancer, infectious disease and numerous other indications,” said Kristin Pothier, founder of DxInsights and partner at Health Advances. “For this reason, we think it’s fitting that the next installment in our ‘Essentials’ series covers this fast-growing and extremely innovative sector of the market, and AdvaMedDx is the perfect partner to collaborate with to bring this educational resource to our health care communities.”

The molecular diagnostics is expected to be released in December.

DxInsights was founded by executives involved in all facets of diagnostics, including development, commercialization, regulatory, reimbursement, and communications. The organization aims to provide the most relevant information in all those areas to create a hub that healthcare executives, medical experts, regulatory officials, the reimbursement community and patients can easily access.

Functioning as an association within AdvaMed, AdvaMedDx is the only advocacy organization dealing exclusively with issues facing diagnostic companies both in the United States and abroad.